EUVIMEDEUVIMED entdecken
Open Access

Integrated 3D-QSAR, molecular docking, molecular dynamics, DFT, in vitro , and in vivo evaluation of benzylidene-thiazolidinedione derivatives as aldose reductase inhibitors

Anita Kumari, Salesh Verma, Preety Kumari, Rupali Kohal, Sidharth Mehan iD, Sant Kumar Verma iD

RSC Medicinal Chemistry · 2026

DOI: 10.1039/d6md00317f ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Anita Kumari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, ISF College of Pharmacy Moga-142 001 Punjab India santkumarverma19@gmail.com. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A benzylidene-thiazolidinedione derivative (SA02) has been discovered as a promising lead aldose reductase inhibitor with good antidiabetic potential.

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, ISF College of Pharmacy Moga-142 001 Punjab India santkumarverma19@gmail.com.
  • Department of Pharmacology, ISF College of Pharmacy Moga-142 001 Punjab India.

ORCID-Profile: Sidharth Mehan, Sant Kumar Verma

Zitieren

APA

Kumari, A., Verma, S., Kumari, P., Kohal, R., Mehan, S., & Verma, S. K. (2026). Integrated 3D-QSAR, molecular docking, molecular dynamics, DFT, in vitro , and in vivo evaluation of benzylidene-thiazolidinedione derivatives as aldose reductase inhibitors. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00317f

Vancouver

Kumari A, Verma S, Kumari P, Kohal R, Mehan S, Verma SK. Integrated 3D-QSAR, molecular docking, molecular dynamics, DFT, in vitro , and in vivo evaluation of benzylidene-thiazolidinedione derivatives as aldose reductase inhibitors. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00317f

BibTeX
@article{Kumari2026,
  author = {Kumari, Anita and Verma, Salesh and Kumari, Preety and Kohal, Rupali and Mehan, Sidharth and Verma, Sant Kumar},
  title = {Integrated 3D-QSAR, molecular docking, molecular dynamics, DFT, in vitro , and in vivo evaluation of benzylidene-thiazolidinedione derivatives as aldose reductase inhibitors},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  doi = {10.1039/d6md00317f}
}
Kostenlos starten →